Sphingosine 1-phosphate-s1pr3 pepducin
Sphingosine 1-phosphate-s1pr3 pepducin has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 11, 2026: “Mimicking Nature, Modulating Vision: Peptidomimetic Neurotrophin Agonists and Emerging Regenerative Strategies in Ocular Disease”.
1 paper studies itUpdated